Artis BioSolutions competitors & alternatives

Landmark BioBiotechUnited States

73% match

Biotech

Landmark Bio is an Artis BioSolutions biotechnology research company headquartered in Watertown, Massachusetts. It is dedicated to accelerating the translation and development of next-generation advanced genetic medicines.

Cirsium BiosciencesLife SciencesUnited States

71% match

Life Sciences

Cirsium Biosciences is a San Diego-based biotech company focused on democratizing gene therapy. The company is redefining AAV production through transformative viral vector production methods and systems.

AGC BiologicsBiotechUnited States

66% match

Biotech

AGC Biologics is a global contract development and manufacturing organization (CDMO) that provides services for protein-based biologics and advanced therapies, including mammalian and microbial production, viral vectors, cell therapy, plasmid DNA, and mRNA. The company supports biopharmaceutical developers by offering process development, analytical formulation, cGMP manufacturing, and fill-finish services to help bring life-changing treatments to market.

Healthcare and Pharmaceuticals

Flash Therapeutics is a French biotechnology company specializing in lentiviral vector technologies and gene-delivery solutions. It serves academic and pharmaceutical/biotechnology researchers, including through development and GMP manufacturing services for gene-therapy applications.

Biotech

ElevateBio is a biotechnology company that builds and operates cell and gene therapy companies and provides development, manufacturing, and technology capabilities through its platform, including BaseCamp. It serves biotech and pharmaceutical organizations developing advanced therapies, as well as supporting the creation of new therapeutic companies.

GenScript1548.HK · BiotechChina

64% matchPublicAI 33/100 ▲Green 5/100 ▼

Biotech

Operating as an investment holding company, Genscript Biotech Corporation, established in 2002 and headquartered in Nanjing, People's Republic of China, specializes in the global provision of innovative life science research solutions, encompassing both products and services. Its market presence spans North America, Europe, China, Japan, other Asia Pacific regions, and numerous international markets. The enterprise structures its operations into four key divisions: The Life Science Services and Products segment delivers a wide array of research offerings, such as gene and oligonucleotide synthesis, molecular cloning, protein and peptide engineering, antibody production, molecular diagnostic instruments, and genomic editing materials. These resources are instrumental for fundamental biological investigations, pharmaceutical and drug discovery, disease diagnostics, vaccine development, and applications in agriculture, environmental science, and food production. The Biologics Development Services division supports pharmaceutical, biotechnology, governmental, and academic institutions. It provides comprehensive services for the full lifecycle of therapeutic antibodies, from initial discovery through pre-clinical and clinical development, alongside pre-clinical and clinical development for plasmids and viruses, and broader gene and cell therapy development. Dedicated to industrial applications, the Industrial Synthetic Biology Products segment engineers non-pathogenic microbial strains and manufactures specialized enzymes. These enzymes find utility across the food processing, animal feed, pharmaceutical, and chemical sectors. Finally, the Cell Therapy unit focuses on the pioneering discovery and advanced development of chimeric antigen receptor T-cell (CAR-T) therapies, specifically designed to combat both liquid and solid malignant tumors.

Biotech

Oxford Biomedica plc is a biopharmaceutical firm focused on the discovery, advancement, and sophisticated bioprocessing of innovative cell and gene therapies. Operating globally, with a strong presence across Europe, the company organizes its activities into two segments: Platform and Product. Its proprietary LentiVector platform technology facilitates the integration of genes into non-dividing cells, such as neurological cells in the brain and retinal cells in the eye, and can incorporate diverse therapeutic genes. The company's developmental pipeline includes promising candidates like Axo-Lenti-PD, a gene-based treatment for Parkinson's disease. Other pre-clinical stage programs feature OXB-302, targeting haematological tumors, and OXB-401, OXB-40X, and OXB-40Y, all addressing liver indications. Oxford Biomedica maintains numerous strategic alliances with prominent pharmaceutical entities such as Novartis, Bristol Myers Squibb, Sio Gene Therapies, Orchard Therapeutics, Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Immatics, Arcellx, and the Vaccines Manufacturing and Innovation Centre. Additionally, it engages in research collaborations, including a partnership with Circularis Biotechnologies to identify novel tissue-specific promoters for in vivo lentiviral gene therapy, Virica Biotech for scaling viral medicines, Isolere Bio for enhancing downstream manufacturing efficiencies of biologics, and BiologIC Technologies for utilizing a novel biocomputer system in viral vector development. Founded in 1995, Oxford Biomedica plc is headquartered in Oxford, United Kingdom.

Forge Biologics Holdings, LLCBiotechUnited States

63% matchPrivate

Biotech

Forge Biologics Holdings, LLC is the parent company of Forge Biologics, a U.S.-based contract development and manufacturing organization focused on gene therapies, particularly adeno-associated virus (AAV) programs. It provides process development, analytical services, and clinical and commercial manufacturing to biotechnology and pharmaceutical companies.

Biotechnology

Junhemeng Biopharmaceutical is a venture-backed biopharmaceutical company established in 2020 and headquartered in Hangzhou, China. The company specializes in developing innovative synthetic biology products and recombinant protein drugs for endocrine and neurotherapy applications. It operates two GMP factories to support full-cycle development from discovery to manufacturing.

Creative BiolabsBiotechnology & PharmaceuticalsUnited States

62% match

Biotechnology & Pharmaceuticals

Creative Biolabs is a biotechnology company that provides custom antibody development, engineering, and manufacturing services for pharmaceutical and research projects.

Samsung BiologicsBiotechSouth Korea

62% match

Biotech

Samsung Biologics operates as a global contract development and manufacturing organization (CDMO) providing end-to-end biopharmaceutical services to pharmaceutical and biotech companies. The company offers a range of services including cell line development, process development, analytical testing, drug substance and drug product manufacturing, and advanced modalities like bioconjugation and mRNA.

Biotechnology

Arranta Bio is a biotechnology contract development and manufacturing organization (CDMO) focused on microbiome-based therapeutics, including live biotherapeutic products. It serves biopharmaceutical companies with process development, analytical, and manufacturing services for these products.